January 30, 2019
Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation
Read More
January 30, 2019
Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation
Read More
January 30, 2019
4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients
Read More
January 30, 2019
4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients
Read More
January 30, 2019
IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1
Read More
January 30, 2019
IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1
Read More
January 30, 2019
Gilead Sustained Virologic Response (SVR) Registry
Read More
January 30, 2019
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Read More
January 30, 2019
Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390
Read More
January 30, 2019
Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option
Read More
January 30, 2019
Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment
Read More
January 30, 2019
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
Read More
Load More
X